Retour aux projets

17072.1 PFLS-LS

17072.1 PFLS-LS

Résumé

Drugs Activated When Needed (DAWN)

Textes supplémentaires

Abstract

The use of delivery vehicles is at the basis of better tolerable and more efficacious novel classes of targeted drugs [termed Antibody- (ADC-)or Small molecule-(SMDC-)Drug Conjugates). Until now the development of ADC and SMDC relies on target cells internalization, which is difficult to measure and exploit. Here we will develop a novel and superior class of ADC and SMDC which will not require internalization of delivery vehicles and will liberate the toxic payload on demand.

Participants

Martin Mattarella

Wirtschaftspartner

(martin.mattarella@philochem.ch

Philochem AG CHE-113.181.443 Martin Mattarella Libernstrasse 3 8112 Otelfingen ZH CH

Dario Neri

Kontaktperson

dario.neri@pharma.ethz.ch

ETH Zürich Inst. of Pharmac. Sciences Dario Neri HCI G496 / Wolfgang-Pauli-Strasse 10 8093 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2014-12-31
Date de fin
2017-12-31
Coûts totaux approuvés
CHF 166021.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%